Chinese biotech firm opens ‘Centre of Excellence’ in Nottingham

The company has moved into MediCity

A Chinese company which focuses on the development of high analytical instruments has moved into Nottingham biotech incubator MediCity.

NanoFCM Co. says the Centre of Excellence will support users of its nanoparticle analysis platform Nano-Flw Cytometry, and will also act as a sales office to serve the Europe, Middle East & Africa region.

The Centre of Excellence is led by Dr Ben Peacock, application scientist, and NanoFCM Co’s managing director Dr Dimitri Aubert, who is also global vice-president for sales and marketing.

“NanoFCM has focused on the Chinese market during its first four years of existence and it has been very successful with the nano-bio research community. We felt this year was the right time to expand internationally, starting with Europe, and shortly afterwards in North America. This network of support and sales offices will allow to sustain a global user base” said Dr Shaobin Zhu, chief executive of NanoFCM Inc.

NanoFCM Co’s parent company, NanoFCM, is headquartered in Xiamen, Fujian province, China.

Close